Strategies in Trauma and Limb Reconstruction

Register      Login

VOLUME 13 , ISSUE 3 ( November, 2018 ) > List of Articles

Original Article

Surgical therapy of benign and low-grade malignant intramedullary chondroid lesions of the distal femur: intralesional resection and bone cement filling with or without osteosynthesis

Georg W. Omlor, Vera Lohnherr, Pit Hetto, Simone Gantz, Jörg Fellenberg, Christian Merle, Thorsten Guehring, Burkhard Lehner

Keywords : Chondroid lesion, Enchondroma, Atypical cartilaginous tumor, Chondrosarcoma, Femur, Compound osteosynthesis

Citation Information : Omlor GW, Lohnherr V, Hetto P, Gantz S, Fellenberg J, Merle C, Guehring T, Lehner B. Surgical therapy of benign and low-grade malignant intramedullary chondroid lesions of the distal femur: intralesional resection and bone cement filling with or without osteosynthesis. 2018; 13 (3):163-170.

DOI: 10.1007/s11751-018-0321-2

License: CC BY-NC-SA 4.0

Published Online: 30-11-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Surgical treatment of benign and low-grade malignant intramedullary chondroid lesions at the distal femur is not well analyzed compared to higher-grade chondrosarcomas. Localization at the distal femur offers high biomechanical risks requiring sophisticated treatment strategy, but scientific guidelines are missing. We therefore wanted to analyze a series of equally treated patients with intralesional resection and bone cement filling with and without additional osteosynthesis. Twenty-two consecutive patients could be included with intralesional excision and filling with polymethylmethacrylate bone cement alone (n = 10) or with compound bone cement osteosynthesis using a locking compression plate (n = 12). Clinical and radiological outcome was retrospectively evaluated including tumor recurrences, complications, satisfaction, pain, and function. Mean follow-up was 55 months (range 7–159 months). Complication rate was generally high with lesion-associated fractures both in the osteosynthesis group (n = 2) and in the non-osteosynthesis group (n = 2). All fractures occurred in lesions that reached the diaphysis. No fractures were found in meta-epiphyseal lesions. No tumor recurrence was found until final follow-up. Clinical outcome was good to excellent for both groups, but patients with additional osteosynthesis had significantly longer surgery time, more blood loss, longer postoperative stay in the hospital, more complications, more pain, less satisfaction, and worse functional outcome. Intralesional resection strategy was oncologically safe without local recurrences but revealed high risk of biomechanical complications if the lesion reached the diaphysis with an equal fracture rate no matter whether osteosynthesis was used or not. Additional osteosynthesis significantly worsened final clinical outcome and had more overall complications. This study may help guide surgeons to avoid overtreatment with additional osteosynthesis after curettage and bone cement filling of intramedullary lesions of the distal femur. Meta-epiphyseal lesions will need additional osteosynthesis rarely, contrary to diaphyseal lesions with considerable cortical thinning.


PDF Share
  1. Jo VY, Fletcher CD (2014) WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 46:95-104
  2. Brown MT, Gikas PD, Bhamra JS, Skinner JA, Aston WJ, Pollock RC, Saifuddin A, Briggs TW (2014) How safe is curettage of lowgrade cartilaginous neoplasms diagnosed by imaging with or without pre-operative needle biopsy? Bone Joint J 96-B:1098-1105
  3. Donthineni R, Ofluoglu O (2010) Solitary enchondromas of long bones: pattern of referral and outcome. Acta Orthop Traumatol Turc 44:397-402
  4. Deckers C, Schreuder BH, Hannink G, de Rooy JW, van der Geest IC (2016) Radiologic follow-up of untreated enchondroma and atypical cartilaginous tumors in the long bones. J Surg Oncol 114:987-991
  5. Andreou D, Gilg MM, Gosheger G, Werner M, Hardes J, Pink D, Leithner A, Tunn PU, Streitbürger A (2016) Metastatic potential of grade I chondrosarcoma of bone: results of a multi-institutional study. Ann Surg Oncol 23:120-125
  6. Altay M, Bayrakci K, Yildiz Y, Erekul S, Saglik Y (2007) Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients. J Orthop Sci 12:415-423
  7. Sampath Kumar V, Tyrrell PN, Singh J, Gregory J, Cribb GL, Cool P (2016) Surveillance of intramedullary cartilage tumours in long bones. Bone Joint J 98:1542-1547
  8. Crim J, Schmidt R, Layfield L, Hanrahan C, Manaster BJ (2015) Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma? Eur J Radiol 84:2222-2230
  9. Van der Geest IC, de Valk MH, de Rooy JW, Pruszczynski M, Veth RP, Schreuder HW (2008) Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1. J Surg Oncol 98:421-426
  10. Hickey M, Farrokhyar F, Deheshi B, Turcotte R, Ghert M (2011) A systematic review and meta-analysis of intralesional versus wide resection for intramedullary grade I chondrosarcoma of the extremities. Ann Surg Oncol 18:1705-1709
  11. Hanna SA, Whittingham-Jones P, Sewell MD, Pollock RC, Skinner JA, Saifuddin A, Flanagan A, Cannon SR, Briggs TW (2009) Outcome of intralesional curettage for low-grade chondrosarcoma of long bones. Eur J Surg Oncol 35:1343-1347
  12. Perisano C, Barone C, Stomeo D, Di Giacomo G, Vasso M, Schiavone Panni A, Maccauro G (2016) Indications for prophylactic osteosynthesis associated with curettage in benign and low-grade malignant primitive bone tumors of the distal femur in adult patients: a case series. J Orthop Traumatol 17:377-382
  13. Evans HL, Ayala AG, Romsdahl MM (1977) Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer 40:818-831
  14. Andreou D, Ruppin S, Fehlberg S, Pink D, Werner M, Tunn PU (2011) Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up. Acta Orthop 82:749-755
  15. Streitbürger A, Ahrens H, Balke M, Buerger H, Winkelmann W, Gosheger G, Hardes J (2009) Grade I chondrosarcoma of bone: the Münster experience. J Cancer Res Clin Oncol 135:543-550
  16. Funovics PT, Panotopoulos J, Sabeti-Aschraf M, Abdolvahab F, Funovics JM, Lang S, Kotz RI, Dominkus M (2011) Low-grade chondrosarcoma of bone: experiences from the Vienna Bone and Soft Tissue Tumour Registry. Int Orthop 35:1049-1056
  17. Campanacci DA, Scoccianti G, Franchi A, Roselli G, Beltrami G, Ippolito M, Caff G, Frenos F, Capanna R (2013) Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton. J Orthop Traumatol 14:101-107
  18. Errani C, Tsukamoto S, Ciani G, Akahane M, Cevolani L, Tanzi P, Kido A, Honoki K, Tanaka Y, Donati DM (2017) Risk factors for local recurrence from atypical cartilaginous tumour and enchondroma of the long bones. Eur J Orthop Surg Traumatol 27:805-811
  19. Schwab JH, Wenger D, Unni K, Sim FH (2007) Does local recurrence impact survival in low-grade chondrosarcoma of the long bones? Clin Orthop Relat Res 462:175-180
  20. Donati D, Colangeli S, Colangeli M, Di Bella C, Bertoni F (2010) Surgical treatment of grade I central chondrosarcoma. Clin Orthop Relat Res 468:581-589
  21. Hirn M, de Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, Carter SR (2009) Bone defects following curettage do not necessarily need augmentation. Acta Orthop 80:4-8
  22. Kundu ZS, Gupta V, Sangwan SS, Rana P (2013) Curettage of benign bone tumors and tumor like lesions: a retrospective analysis. Indian J Orthop 47:295-301
  23. Dierselhuis EF, Gerbers JG, Ploegmakers JJ, Stevens M, Suurmeijer AJ, Jutte PC (2016) Local treatment with adjuvant therapy for central atypical cartilaginous tumors in the long bones: analysis of outcome and complications in one hundred and eight patients with a minimum follow-up of two years. J Bone Joint Surg Am 98:303-313
  24. Collins NJ, Misra D, Felson DT, Crossley KM, Roos EM (2011) Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS). Arthritis Care Res (Hoboken) 63:208-228
  25. Dijstra S, Wiggers T, van Geel BN, Boxma H (1994) Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures. Eur J Surg 160:535-542
  26. Busam ML, Esther RJ, Obremskey WT (2006) Hardware removal: indications and expectations. J Am Acad Orthop Surg 14:113-120
  27. Di Giorgio L, Touloupakis G, Vitullo F, Sodano L, Mastantuono M, Villani C (2011) Intralesional curettage, with phenol and cement as adjuvants, for low-grade intramedullary chondrosarcoma of the long bones. Acta Orthop Belg 77:666-669
  28. Staats K, Panotopoulos J, Tiefenboeck TM, Windhager R, Funovics PT (2017) Computer navigation-assisted surgery for musculoskeletal tumors: a closer look into the learning curve. Eur J Orthop Surg Traumatol 27:851-858
  29. Chen X, Yu LJ, Peng HM, Jiang C, Ye CH, Zhu SB, Qian WW (2017) Is intralesional resection suitable for central grade 1 chondrosarcoma: a systematic review and updated meta-analysis. Eur J Surg Oncol 43:1718-1726
  30. Piccioli A, Ventura A, Maccauro G, Spinelli MS, Del Bravo V, Rosa MA (2011) Local adjuvants in surgical management of bone metastases. Int J Immunopathol Pharmacol 24:129-132
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.